Submission Information

ABSTRACTS

Key Dates

Abstract Submissions Open March 16, 2026 Abstract Submissions Close June 10, 2026
Submit Abstract Here

Why Present at ISCT?

Poster Session Interaction
Presentation and Audience

Showcase & Collaborate

Showcase your research through 3 dedicated oral abstract sessions, 2 poster sessions, and networking receptions designed to spark new collaborations.

Translational

Share basic research, clinical investigations, manufacturing, regulatory, and commercialization work with the CGT community.

Visibility & Impact

Present to an expert audience across academia, industry, and regulatory sectors, increasing the visibility and impact of your research. Accepted abstracts will be published in the ISCT Asia 2026 Regional Meeting Program.

Launch Your Career

Present your work and connect with peers and mentors. Abstract awards are available to help recognize and support emerging researchers.

Poster Hall
ISCT Asia 2026 Regional will feature a large Poster Hall open to delegates throughout the meeting. In addition, ISCT Asia 2026 Regional will host two dedicated poster networking receptions during which all meeting delegates gather in the Poster Hall to review research, discuss findings and network with presenters.
Oral Presentations
High-scoring abstracts will be invited to give a 10-minute presentation of their work at one of many oral abstract sessions.

ABSTRACT AWARD GENERAL ELIGIBILITY CRITERIA

Current 2026 Membership

Recipient must hold current 2026 ISCT membership.

Present In-Person

Recipient must present the abstract in-person at ISCT Asia 2026 Regional.

One Award Per Recipient

Recipient cannot win multiple awards.

ISCT Asia 2026 Singapore Abstract Categories
  • Mesenchymal Stem/Stromal Cells
  • Hematopoietic Stem/Progenitor Cells and Engineering
  • Immunotherapy (CAR-T, T Reg, NK Cells etc.)
  • Exosomes/EVs
  • iPSC
  • Gene Editing/Gene Therapies
  • Tissue Engineering
  • Embryonic, Organ and Other Tissue Specific Stem Cells
  • Process Development & Manufacturing and Commercialization
  • Regulatory Affairs, Quality Systems, Policy, Ethics, and Patient Access
  • Workforce Development

General Guidelines
  • ISCT membership is not required to submit and present an abstract.
  • The abstract body cannot exceed 2,500 characters, exclusive of the title, author block, images, and tables.
  • Note that spaces count as characters.
  • Ensure that any references to licensed products are labelled with their non-proprietary names.
  • Abstracts must be submitted via the online Abstract Submission System. Abstracts will not be accepted by email, mail, or fax.
  • There are limited opportunities for oral talks. Invitations to give an oral presentation are based on the quality and scope of the submitted abstract as determined through our blinded-review process.
  • The inclusion of all relevant data to your topic is strongly encouraged as Reviewers will evaluate this when scoring submitted abstracts.
  • ISCT may reject abstracts that are considered inappropriate for any reason. Abstracts, once submitted, can only be withdrawn no later than July 27, 2026. If not withdrawn by this deadline, all accepted abstracts will be published in the final program and abstract supplement.
  • Abstract presenters must have full conference registration to present at the meeting.
Embargo Policy
  • Abstracts submitted to the ISCT Asia 2026 Regional Meeting is embargoed from the time of submission until 23:59 SGT August 25, 2026
  • To be eligible for presentation, information within the abstract (and additional data to be presented) may not be published elsewhere or made public before the abstract has been published/presented at the ISCT 2026 Asia 2026 Regional Meeting.
  • Authors must notify ISCT if, after the submission deadline, the submitted abstract is accepted for publication elsewhere and will be published before the meeting. Publication before the meeting may result in the abstract being removed from the conference.
  • If the Embargo Policy is violated, the abstract may be withdrawn by ISCT from presentation and from publication in the abstract supplement.

* An embargo means that information from any abstract or presentation may not be announced, publicized, or distributed before the embargo date and time.

Encore Abstract Policy
  • ISCT generally does not accept encore abstracts unless there are substantial data updates.
  • Exceptions may be granted upon written request to fajar@isctglobal.org, with a clear justification for the encore abstract (e.g., if the ISCT audience significantly differs from the initial presentation).

* An encore abstract is the resubmission of an original abstract that has previously been presented at another conference.